IL310102A - History of Korormicn with use as an antibiotic - Google Patents

History of Korormicn with use as an antibiotic

Info

Publication number
IL310102A
IL310102A IL310102A IL31010224A IL310102A IL 310102 A IL310102 A IL 310102A IL 310102 A IL310102 A IL 310102A IL 31010224 A IL31010224 A IL 31010224A IL 310102 A IL310102 A IL 310102A
Authority
IL
Israel
Prior art keywords
compound
independently selected
peg
carbon atoms
hydrocarbon chain
Prior art date
Application number
IL310102A
Other languages
English (en)
Hebrew (he)
Original Assignee
Viotika Life Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viotika Life Science Inc filed Critical Viotika Life Science Inc
Publication of IL310102A publication Critical patent/IL310102A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL310102A 2015-04-23 2016-04-22 History of Korormicn with use as an antibiotic IL310102A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562151902P 2015-04-23 2015-04-23
PCT/CA2016/050470 WO2016168938A1 (en) 2015-04-23 2016-04-22 Derivatives of korormicin useful as antibiotics

Publications (1)

Publication Number Publication Date
IL310102A true IL310102A (en) 2024-03-01

Family

ID=57142747

Family Applications (2)

Application Number Title Priority Date Filing Date
IL310102A IL310102A (en) 2015-04-23 2016-04-22 History of Korormicn with use as an antibiotic
IL255182A IL255182B2 (en) 2015-04-23 2016-04-22 History of Korormicn with use as an antibiotic

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL255182A IL255182B2 (en) 2015-04-23 2016-04-22 History of Korormicn with use as an antibiotic

Country Status (8)

Country Link
US (5) US10166213B2 (cg-RX-API-DMAC7.html)
EP (1) EP3285762A4 (cg-RX-API-DMAC7.html)
JP (3) JP6842089B2 (cg-RX-API-DMAC7.html)
CN (2) CN116574132A (cg-RX-API-DMAC7.html)
AU (4) AU2016253429B2 (cg-RX-API-DMAC7.html)
CA (1) CA2983460A1 (cg-RX-API-DMAC7.html)
IL (2) IL310102A (cg-RX-API-DMAC7.html)
WO (1) WO2016168938A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3285762A4 (en) * 2015-04-23 2019-02-06 Dibrov, Pavel DERIVATIVES OF KORORMICIN AS ANTIBIOTICS
CN116617231B (zh) * 2023-06-12 2024-11-15 沈阳药科大学 2-氨基萘嵌间二氮杂苯氢溴化物增强对革兰氏阴性菌杀菌作用的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2315489A (en) * 1996-07-17 1998-02-04 Merck & Co Inc Antifungal agent
JP3905604B2 (ja) * 1997-03-04 2007-04-18 株式会社海洋バイオテクノロジー研究所 新規化学物質コロールミシン
JP2000281670A (ja) 1999-03-26 2000-10-10 Marine Biotechnol Inst Co Ltd 新規コロールミシン合成中間体及び製造法
JP2000336088A (ja) * 1999-05-27 2000-12-05 Marine Biotechnol Inst Co Ltd 新規化学物質F420m類縁体
JP2001010908A (ja) 1999-06-28 2001-01-16 Marine Biotechnol Inst Co Ltd 防汚剤
JP2003061645A (ja) 2001-08-23 2003-03-04 Marine Biotechnol Inst Co Ltd 海洋細菌の選択培地
WO2008116029A1 (en) * 2007-03-19 2008-09-25 Wisconsin Alumni Research Foundation Modulation of bacterial quorum sensing with synthetic ligands
US8501969B2 (en) * 2009-07-03 2013-08-06 The National Institute for Biotechnology in the Negev Ltd. Covalent inhibition of bacterial quorum sensing
EP3285762A4 (en) * 2015-04-23 2019-02-06 Dibrov, Pavel DERIVATIVES OF KORORMICIN AS ANTIBIOTICS

Also Published As

Publication number Publication date
IL255182A0 (en) 2017-12-31
US10166213B2 (en) 2019-01-01
US20190083450A1 (en) 2019-03-21
CN107708689A (zh) 2018-02-16
US20240358670A1 (en) 2024-10-31
IL255182B2 (en) 2024-06-01
EP3285762A1 (en) 2018-02-28
AU2020267205A1 (en) 2020-12-10
EP3285762A4 (en) 2019-02-06
WO2016168938A1 (en) 2016-10-27
US10744111B2 (en) 2020-08-18
US12029716B2 (en) 2024-07-09
JP2018513194A (ja) 2018-05-24
AU2019202254B2 (en) 2020-08-13
JP6842089B2 (ja) 2021-03-17
JP2022122857A (ja) 2022-08-23
CA2983460A1 (en) 2016-10-27
AU2016253429B2 (en) 2019-01-03
AU2022204906A1 (en) 2022-07-28
AU2020267205B2 (en) 2022-04-14
AU2022204906B2 (en) 2024-03-28
US20220257555A1 (en) 2022-08-18
JP7121225B2 (ja) 2022-08-18
AU2019202254A1 (en) 2019-05-02
US11324716B2 (en) 2022-05-10
AU2016253429A1 (en) 2017-12-07
JP2021073278A (ja) 2021-05-13
CN116574132A (zh) 2023-08-11
US20180064680A1 (en) 2018-03-08
IL255182B1 (en) 2024-02-01
US20200345682A1 (en) 2020-11-05

Similar Documents

Publication Publication Date Title
US20240358670A1 (en) Derivatives of korormicin useful as antibiotics
Poelarends et al. Multidrug transporters and antibiotic resistance in Lactococcus lactis
Wu et al. Bacillomycin D effectively controls growth of Malassezia globosa by disrupting the cell membrane
AU2003267079B2 (en) Factors that bind intestinal toxins
US8748661B2 (en) Polyamino polyketide antibiotics and uses thereof
KR100251888B1 (ko) 긴 사슬의 지방족 알콜을 가진 아실카르니틴 에스테르와 항박테리아 활성을 지닌 그의 약제조성물
Ohsuka et al. Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways
US20030147930A1 (en) Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives
CA2413284A1 (fr) Utilisation d'acides en c4-c10 pour la prevention des infections a bacteries a gram negatif
JP6590924B2 (ja) 微生物感染を治療するための相乗的組成物
Kassab DEVELOPMENT OF NOVEL ANTIMICROBIAL TETRACYCLINE ANALOG B (IODOCYCLINE) BY CHEMO-INFORMATICS.
Wang et al. Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii
HK40087860A (zh) Capsaicyns在治疗肠漏中的应用
Ray Catecholamines and Biofilm
Dibrov Searching for New Antimicrobial Targets: Na+ Cycle in Energetics of Bacterial Pathogens
Bartoszewicz et al. It's getting worse: antibiotic resistance among opportunistic pathogens
CN119837893A (zh) 5-氟-2′-脱氧胞苷在制备抗菌药物中的用途
Osborne Antimicrobials and antimicrobial resistance: two studies investigating different ways to tackle the issue
Machado The Inhibitory Activity of Synthetic Compounds and Ions Against Transporters of Multi-drug Resistant Bacteria